Clinical Trial Update: Ivacaftor for Acquired CFTR Dysfunction in Chronic Rhinosinusitis [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 clinical trial evaluating ivacaftor for acquired CFTR dysfunction in chronic rhinosinusitis, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinosinusitis

Drugs mentioned

• Ivacaftor (ivacaftor)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Chronic Rhinosinusitis (Diagnosis) | EARLY_Phase 1 | Status: RECRUITING